Article of the day, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn:
“Article of the day! Suggest by the Immune Oncology Research Institute.
Authors: Meghan Mooradian, Ling Cai, Yao Qiao, Pratibha Chander, Ryan Whitaker, Yao Qiao, Pratibha Chander and Ryan M. Whitaker.
Author Affiliations: Massachusetts General Hospital, Vanderbilt University Medical Center, et al.”
Source: Immune Oncology Research Institute/LinkedIn
Immune Oncology Research Institute (IMMONC), established in 2022, is a non-profit, independent, patient-centered research institute. The mission of IMMONC is to advance the cancer knowledge and care through breakthrough scientific research, to integrate innovative immune-oncology therapies into the clinical practice for different types of cancers, to generate and collect clinical data for the identification of new therapeutic targets, developing predictive models and optimizing patient outcomes, to increase the availability and accessibility of those discoveries for the cancer patients, to create a world-class professional environment, to attract the brightest minds in cancer field and to train the next generation researchers.